Radiation recall dermatitis from docetaxel

Onkologie

Volumn 25, Issue 5, 2002, Pages 438-440

  Piroth, Marc D ^a   Krempien, R ^b   Wannenmacher, M ^b   Zierhut, D ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

Docetaxel; Radiation dermatitis; Radiochemotherapy; Recall phenomenon

Indexed keywords

DOCETAXEL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DESQUAMATION; DISEASE SEVERITY; ELECTRON; ERYTHEMA; FEMALE; HUMAN; IRRADIATION; PELVIS; RADIATION DOSE; SKIN MANIFESTATION;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; PACLITAXEL; RADIODERMATITIS; RADIOTHERAPY, ADJUVANT; RECURRENCE; TAXOIDS;

EID: 0036977302     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067438     Document Type: Article

References (16)

1. Bokemeyer C, Lampe C, Heneka M, Schabet M, Bamberg M, Kanz L: Paclitaxel-induced radiation recall dermatitis. Ann Oncol 1996;7:755-757.
2. Burdon J, Bell R, Sullivan J, et al: Adriamycin-induced recall-phenomen 15 years after radiotherapy. JAMA 1978;239:931 (letter).
3. D'Angio GJ, Farber S, Maddock CL: Potentiation of X-ray effects of actinomycin D. Radiology 1959;73:175-177.
4. Giesel BU, Gudrun G, Thiel HJ: Recall-dermatitis durch Docetaxel-Reexposition nach Ganzhirnbestrahlung. Strahlenther Onkol 2001;177:487-93.
5. Hesse K, Heinrich B, Zimmermann F, Kau R, Sommer G, Achterrath W, Molls M, Feldmann HJ: Combined chemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors. Strahlenther Onkol 2000;176:67-72.
6. Hortobagyi GN: Anthracyclines in the treatment of cancer. An overview. Drugs 1997;54:1-7.
7. Creane M, Seymour CB, Colucci S, Mothersill C: Radiobiological effects of docetaxel (Taxotere): A potential radiosensitizer. Int J Radiat Biol 1999;75:731-737.
8. Pradier O, Rave-Frank M, Lehmann J, Lucke E, Boghun O, Hess CF, Schmidberger H: Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CASKI). Int J Cancer 2001;91:840-845.
9. Cortes JE, Pazdur R: Docetaxel. J Clin Oncol 1995;13:2643-2655.
10. Yeo W, Leung SF, Johnson PJ: Radiation-recall dermatitis with docetaxel: Establishment of a requisite radiation threshold. Eur J Cancer 1997;33:698-699.
11. Camidge R, Kunkler IH: Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol 2000;12:272-273.
12. Burstein HJ: Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine. J Clin Oncol 2000;18:693-694.
13. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001;59:237-245.
14. Kitani H, Kosaka T, Fujihara T, Lindquist K, Elkind MM: The 'recall effect' in radiotherapy: Is subeffective, reparable damage involved? Int J Radiat Oncol Biol Phys 1990;18:689-695.
15. Bronner AK, Hood AF: Cutaneous complications of chemotherapeutic agents. J Am Acad Dermatol 1983;9:645-663.
16. Kellie SJ, Plowman PN, Malpas JS: Radiation recall and radiosensitization with alkylating agents. Lancet 1987;1:1149-1150.